Global Coalition on Aging to Be Honored by American Federation for Aging Research

GCOA and AFAR Celebrate Innovation in Aging

NEW YORK CITY (April 15, 2013) – This evening Michael W. Hodin, PhD, executive director of the Global Coalition on Aging (GCOA), will receive the Fred D. Thompson Award of Distinction from the American Federation for Aging Research (AFAR) at AFAR’s Annual Awards Dinner in New York City.

The award, named in honor of the founding chairman of AFAR’s Board of Directors, is presented to individuals who have demonstrated an outstanding commitment to the field of aging research through activities and support of those involved in the field.

“It is a high honor to be recognized by the American Federation for Aging Research, an organization that is playing such a critical role in advancing our knowledge of and innovation around healthy aging,” said Hodin.  “I will proudly accept this award on behalf of all of the members, advisors and staff of the Global Coalition, who are so steadfastly committed to making aging a path for economic prosperity and personal wellbeing.”

Each year, AFAR recognizes the achievements of individuals and organizations whose work has impacted the field of aging research and improved public health.  For more than 30 years, AFAR has supported the science of healthier aging and advanced the knowledge base of age-related diseases by providing grants to support biomedical research of nearly 3,000 talented scientists.

“In just over two years, the Global Coalition on Aging, with its optimistic perspective and innovative approach to business and public policy, has helped place the spotlight on the opportunities of healthy aging,” said Stephanie Lederman, executive director of AFAR. “AFAR congratulates Mike Hodin and the Global Coalition on Aging for its leadership in advancing the global dialogue on population aging and looks forward to working together as we strive to meet our mutual goals.”

“Through Mike’s energy, enthusiasm and amazing networks, he has led the Global Coalition to become a real leader in the field of aging. It is incredible success for such a small organization to have achieved on such a crucial issue for our times,” said John Beard, Director of the Department of Ageing and Life Course at the World Health Organization.  “Our capacity to exert global influence on aging would be much less if Mike and the Global Coalition had not been such a close and supportive partner.”

This evening’s AFAR dinner will also honor Brian Daniels, MD, Senior Vice President, Global Development and Medical Affairs at Bristol-Myers Squibb and include a posthumous tribute to George Doty, a founding member of AFAR’s Board, and his wife Marie.

In conjunction with the AFAR Annual Awards Dinner, AFAR and GCOA are hosting an afternoon symposium titled “Innovation and the Future of Healthy Aging,” bringing together some of world’s leading business executives and academics driving changes centered on healthy aging.  Topics to be discussed include nutrition, technology and policy and investment.  Speakers include:

  • Richard W. Besdine, MD, AFAR Medical Officer and Professor of Medicine and of Health Services, Alpert Medical School of Brown University
  • Caroline Blaum, MD, Division of Geriatrics, New York University
  • Joseph Coughlin, Director, AgeLab, Massachusetts Institute of Technology
  • William Green, Director, Public Affairs & Relations, Nutricia (Danone)
  • Jennifer Grossman, Senior Vice President, Dole Nutrition Institute
  • Michael Hodin, Executive Director, Global Coalition on Aging
  • Shawn Morris, President of Development and Innovation, HealthSpring (Cigna)
  • Robert Romasco, President, AARP
  • Paul Simonetti, Consultant, Health & Wellness
  • Jack Watters, Vice President, External Medical Affairs, Pfizer

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

Canary in the Coal Mine: Learnings from COVID-19 for Health Ecosystems in an Ageing World

In this webinar, expert speakers from ILC-UK, Johns Hopkins University, and the Global Coalition on Aging will explore what we are learning from the experience of older adults in COVID-19 about how health ecosystems – from the central healthcare system to care settings, caregivers, employers, and individuals – all must adapt to the needs of an ageing society, both during the pandemic and beyond.

Reflections on Empowerment: The COVID-19 Pandemic Reinforces the Need for Solidarity and a Focus on our Life Priorities

The New Social Contract: Empowering individuals in a transitioning world, a global survey report published by Aegon in 2019, identifies people’s top four current life priorities as: being healthy and fit (62%), enjoying life (59%), planning for their financial future (49%), and focusing on family (45%). Since the end of last year, the entire world has been upended by COVID-19.

Financial Times Letter to the Editor

Brenden Greeley’s “The economy is king in Donald Trump’s re-election bid” (Opinion, December 20) accurately and optimistically concludes that our US economy will “get [another] massive wave of hiring around mid-year”. But in his earlier, also accurate assessment that “working age adults continue to join the workforce” he misses another, equally powerful piece of the puzzle: for employers and policymakers in any growth economy to take the necessary 21st-century step of opening jobs to those of us over the quaint 20th-century retirement age of 60 or so.

Global Coalition on Aging and Pfizer Global Medical Grants Partner to Launch Grant Program to Increase Vaccine Usage Among Older Adults in Japan

New York, NEW YORK (November 19, 2019) – The Global Coalition on Aging (GCOA) and Pfizer Global Medical Grants today officially launched a partnership to improve uptake of vaccines among Japanese older adults. Through $1 million USD in grant awards, the Vaccines for All: Longevity Unleashed for Everyone (VALUE) initiative will support, advance, and validate quality improvement strategies that measurably increase the number of older adults in Japan who are immunized against at least one targeted vaccine-preventable disease.